Not admitted · Third-party claim
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 27 Oct 2023 · owen-0745
Quote
Third-party claim
“The OLO trial will enroll up to 1,000 adults in a major depressive episode who have failed to receive satisfactory improvement from a prior antidepressant medication in the current episode.”
Press Release Round Up, item II: Fermata press release (Oct. 25, 2023) announcing Fermata as a site in the SAINT open-label optimization (OLO) multi-site trial of the Magnus SAINT Neuromodulation System for MDD. The release states the trial will enroll up to 1,000 adults with treatment-resistant depression.
A quoted or paraphrased claim by someone else that the author does not adopt as their own.